Formulation and in-Vitro Evaluation of Gastroretentive Floating Tablets of Axitinib: Optimization Using 33 Full Factorial Design of Experiments
Oriental Journal Of Chemistry · 26.06.2026 · 3 (42) · 924
DOI: 10.13005/ojc/420313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oriental Journal Of Chemistry, online erschienen am 25.06.2026. Verfasst von Sangmesh Mallikarjun Chaudhari und 1 weiteren Autor:innen. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Axitinib, a selective vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor approved for the management of advanced renal cell carcinoma, exhibits pH-dependent solubility and a narrow absorption window predominantly confined to the gastric and proximal intestinal mucosa. Rapid gastric transit of conventional oral dosage forms limits effective drug absorption, leading to erratic plasma concentrations and suboptimal therapeutic outcomes. The present study aimed to develop and optimize a gastroretentive floating tablet system of axitinib to enhance gastric residence time, promote drug dissolution in the acidic gastric environment, and improve oral bioavailability. Floating tablets were manufactured by direct compression employing hydroxypropyl methylcellulose (HPMC K4M/K100M) as the hydrophilic matrix-forming polymer and sodium bicarbonate as the effervescent gas-generating agent. A 3³ full factorial Design of Experiments (DoE) was applied to evaluate the independent and interactive effects of HPMC concentration (X₁: 15–25% w/w), Carbopol 934P (X₂: 2–6% w/w), and sodium bicarbonate (X₃: 5–10% w/w) on critical quality attributes including floating lag time, total floating time, drug release at 12 h, and tablet hardness. Three-dimensional response surface plots were generated for visual interpretation of factor–response relationships. Preformulation studies confirmed axitinib's physicochemical suitability and excipient compatibility. All formulations demonstrated acceptable powder flow and post-compression parameters. In-vitro buoyancy studies showed rapid floating onset (9 h across all batches. The optimized formulation F14 exhibited a floating lag time of 44 ± 2 s, total floating duration of 13.4 ± 0.7 h, and cumulative drug release of 94.6 ± 1.5% at 12 h following Korsmeyer–Peppas and Higuchi release kinetics (n = 0.63), indicating diffusion-controlled non-Fickian transport. Gastroprotective evaluation confirmed structural integrity and pH stability over 12 h. The developed floating gastroretentive system represents a promising platform for enhancing axitinib biopharmaceutical performance.
Zitieren
APA
Chaudhari, S. M., & Thagale, R. (2026). Formulation and in-Vitro Evaluation of Gastroretentive Floating Tablets of Axitinib: Optimization Using 33 Full Factorial Design of Experiments. Oriental Journal Of Chemistry, 3(42), 924. https://doi.org/10.13005/ojc/420313
Vancouver
Chaudhari SM, Thagale R. Formulation and in-Vitro Evaluation of Gastroretentive Floating Tablets of Axitinib: Optimization Using 33 Full Factorial Design of Experiments. Oriental Journal Of Chemistry. 2026;3(42):924. doi:10.13005/ojc/420313
BibTeX
@article{Chaudhari2026,
author = {Chaudhari, Sangmesh Mallikarjun and Thagale, Rajkumari},
title = {Formulation and in-Vitro Evaluation of Gastroretentive Floating Tablets of Axitinib: Optimization Using 33 Full Factorial Design of Experiments},
journal = {Oriental Journal Of Chemistry},
year = {2026},
volume = {3},
number = {42},
pages = {924},
doi = {10.13005/ojc/420313}
}
EUVIMED